Global capacity Leverage Unither's global footprint across Europe, the Americas and Asia to offer reliable, scalable sterile unit‑dose manufacturing for multinational clients, with flexible capabilities spanning blow‑fill‑seal, multi‑doses, bottles and suppositories.

Vaccine collaborations Capitalize on active vaccine and biologics initiatives and industry partnerships highlighted by World Vaccine Congress participation and joint development efforts to position Unither as a preferred manufacturing partner for prophylactics and infectious‑disease programs.

Ophthalmic niche Target ophthalmic and other niche therapies by aligning with existing co‑development arrangements to offer integrated sterile unit‑dose manufacturing for eye drugs and related specialty products.

Expansion readiness Showcase recent and planned expansions such as the Gannat site development and new BFS production lines in China to reassure clients of scalable capacity and resilient supply for upcoming launches and market growth.

One stop CDMO Position Unither as an end‑to‑end partner capable of co‑developing, manufacturing and packaging a broad range of sterile dosage forms, enabling customers to consolidate vendors and streamline global supply chains.